FR2752382B1 - Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique - Google Patents

Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique

Info

Publication number
FR2752382B1
FR2752382B1 FR9610258A FR9610258A FR2752382B1 FR 2752382 B1 FR2752382 B1 FR 2752382B1 FR 9610258 A FR9610258 A FR 9610258A FR 9610258 A FR9610258 A FR 9610258A FR 2752382 B1 FR2752382 B1 FR 2752382B1
Authority
FR
France
Prior art keywords
human
treatment
therapeutic use
animal products
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9610258A
Other languages
English (en)
Other versions
FR2752382A1 (fr
Inventor
Jean Gerota
Pablo Goldschmidt
Roger Gouezo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR9610258A priority Critical patent/FR2752382B1/fr
Priority to PCT/FR1997/001493 priority patent/WO1998007457A1/fr
Publication of FR2752382A1 publication Critical patent/FR2752382A1/fr
Application granted granted Critical
Publication of FR2752382B1 publication Critical patent/FR2752382B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9610258A 1996-08-16 1996-08-16 Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique Expired - Fee Related FR2752382B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9610258A FR2752382B1 (fr) 1996-08-16 1996-08-16 Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique
PCT/FR1997/001493 WO1998007457A1 (fr) 1996-08-16 1997-08-14 Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610258A FR2752382B1 (fr) 1996-08-16 1996-08-16 Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique

Publications (2)

Publication Number Publication Date
FR2752382A1 FR2752382A1 (fr) 1998-02-20
FR2752382B1 true FR2752382B1 (fr) 1998-10-09

Family

ID=9495093

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9610258A Expired - Fee Related FR2752382B1 (fr) 1996-08-16 1996-08-16 Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique

Country Status (2)

Country Link
FR (1) FR2752382B1 (fr)
WO (1) WO1998007457A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854490C2 (de) * 1978-12-16 1981-04-09 B. Braun Melsungen Ag, 3508 Melsungen Knochenersatzmaterial mit verbesserter biologischer Stabilität auf Basis von Kollagen
EP0424159A3 (en) * 1989-10-19 1991-11-06 Osteotech, Inc., Aseptic processing of allograft bone and tissue
FR2654625B1 (fr) * 1989-11-22 1992-02-21 Transphyto Sa Procede de fabrication d'un materiau pour osteoplastie a partir d'un tissu osseux naturel et materiau obtenu par ce procede.
RU1835269C (ru) * 1990-11-26 1993-08-23 Оренбургский Государственный Медицинский Институт Обтуратор бронха

Also Published As

Publication number Publication date
WO1998007457A1 (fr) 1998-02-26
FR2752382A1 (fr) 1998-02-20

Similar Documents

Publication Publication Date Title
FR2619003B1 (fr) Appareil ultrasonore de traitement therapeutique
FR2671289B1 (fr) Procede et appareil pour eliminer des agents de combat chimiques et biologiques de l'air pour permettre sa consommation par l'homme.
DE69731309D1 (de) Impfstofformel auf polynukleotidbasis zur behandlung von hundekrankheiten, insbesondere solcher des atmungs- und verdauungstraktes
DE59607691D1 (de) Anordnung zur elektro-thermischen behandlung des menschlichen oder tierischen körpers
FR2739255B1 (fr) Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IT9083334A0 (it) Procedimento per l'estrazione e la purificazione di dna genomico umano
DE69529307T2 (de) Ultraschall-Diagnose- und Behandlungssystem
FR2754713B1 (fr) Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
FR2777466B1 (fr) Appareil de traitement de tumeur
FR2736261B1 (fr) Produit d'hygiene capillaire ou de traitement pileux
FR2649324B1 (fr) Article souple pour traitement chirurgical, ensemble le comprenant et son procede d'utilisation
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
FR2674844B1 (fr) Procede et installation de traitement d'epuration de lisiers d'animaux.
ATA113492A (de) Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven
FR2752382B1 (fr) Procede de traitement de produits d'origine humaine ou animale destines a une utilisation therapeutique
FR2614203B1 (fr) Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
TNSN95068A1 (fr) Oligonucleotides pour inhiber le role des isoprenyl proteine transferases
FR2630099B1 (fr) Procede de traitement et de purification d'eaux
DE3790919T1 (de) Arzneimittel zur prophylaxe und behandlung von gastrointerfinalen erkrankungen des landwirtschaftsviehs
FR2613621B1 (fr) Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
FR2804685B1 (fr) Utilisation d'une proteine de leptospire pour la prevention et/ou le diagnostic et/ou le traitement de la leptospirose animale et/ou humaine
FR2600531B1 (fr) Appareil pour le traitement d'etats pathologiques par stimulation de points d'acupuncture.

Legal Events

Date Code Title Description
ST Notification of lapse